|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6018
| ABSTRACT |
|---|
|
|
|---|
gamete biology, kinases, meiosis, oocyte development
| INTRODUCTION |
|---|
|
|
|---|
Overexpression of CDC6 during the late S phase activates CHEK1 kinase. This prevents cyclin B/CDK1 activation and leads to cell-cycle arrest at the G2/M-phase transition [12]. Detailed analysis of this phenomenon in Xenopus laevis has demonstrated that CDC6 activates CHEK1 directly and that MCM proteins as well as binding of CDC6 to chromatin are not required [13].
The difference in how the amount of CDC6 protein is regulated after the initiation of DNA replication in different eukaryotes raises the possibility that CDC6 has other functions during the late S phase and mitosis in mammals. To investigate this possibility in mammalian somatic cells, however, is difficult, both because a CDC6-specific inhibitor is lacking and because a Cdc6 knockout or an RNA interference (RNAi)-mediated knockdown would be lethal. Mouse oocytes are a potentially suitable system to explore this possibility. Mouse oocytes are arrested in the first meiotic prophase after DNA replication; this is similar to being arrested at the G2/M-phase transition. Cyclin B/CDK1 (i.e., M-phase promoting factor [MPF]) activity is low in these oocytes, which is similar to somatic cells at the G2/M-phase transition. Resumption of meiosis entails an abrupt activation of MPF that leads to dissolution of the nuclear membrane (i.e., germinal vesicle breakdown [GVBD]), two rounds of chromosome segregation with no intervening DNA replication, and arrest at metaphase II [14].
We first analyzed whether overexpression of CDC6 inhibits GVBD. We found that in contrast to somatic cells, oocytes tolerate high levels of CDC6; that is, the oocytes mature normally and arrest at metaphase II. Reducing CDC6 by RNAi demonstrated that although GVBD occurred and chromosomes condensed, a spindle failed to form, suggesting a new function for CDC6 that is not related to DNA replication.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Fully grown, germinal vesicle (GV)-intact oocytes were obtained from eCG-primed, 6-wk-old, female CF-1 mice (Harlan) and freed of attached cumulus cells as previously described [15]. The collection medium was bicarbonate-free minimal essential medium (Earle salt) supplemented with 3 mg/ml of polyvinylpyrrolidone (PVP) and 25 mM Hepes (pH 7.3). Germinal vesicle breakdown was inhibited by adding 0.2 mM 3-isobutyl-1-methyl-xanthine (IBMX) to the isolation or culture media. Oocytes were cultured in CZB medium [16] containing 0.2 mM IBMX and cultured in an atmosphere of 5% CO2 in air at 37°C. Oocytes were microinjected in bicarbonate-free Whitten medium [17] supplemented with 10 mM Hepes (pH 7.3) and 0.2 mM IBMX with 5 pl of the RNA solution; the injections were performed as previously described [18]. Typically, greater than 70% of oocytes injected with either Egfp or Cdc6 double-stranded (ds) RNA survived, and virtually all the surviving oocytes underwent GVBD. The dsRNA was diluted to 12 µg/µl and mRNAs to 0.5 µg/µl for injections. After microinjection, oocytes were cultured in CZB plus IBMX for 2 h when mRNA was injected and 24 h when dsRNA was injected. When required, the injected oocytes were matured by washing and culturing them in IBMX-free CZB medium for 18 h.
All animal experiments were approved by the Institutional Animal Use and Care Committee and were consistent with National Institutes of Health guidelines.
RNA Isolation and Quantification
Total RNA from 5 to 50 oocytes or eggs was isolated using the Absolutely RNA Microprep Kit (Stratagene, La Jolla, CA). The reverse transcription (RT) reaction, primed with random hexamers, was performed using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. Total RNA isolated from 5 to 50 oocytes was reverse transcribed in 20-µl reactions. The resulting cDNA was quantified by real-time polymerase chain reaction (PCR) using SybrGreen and detecting the threshold cycle with an ABI Prism 7000 (Applied Biosystems, Foster City, CA). Histone H1foo was used as an internal standard. The following primers were used: histone H1foo, 5'-GCGAAACCGAAAGAGGTCAGAA-3' and 5'-TGGAGGAGGTCTTGGGAAGTAA-3,'; and CDC6, 5'-GTGCTGCGATCCAGTTCTGT-3' and 5'-CTGCAAGTGCCATGAGTAAGA-3'.
Mutagenesis of Phosphorylation Sites
The QuikChange Multisite-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) was used to produce mouse CDC6 with serine residues 55, 75, and 108 mutated to alanine or aspartic acid residues. The template for reaction was a pCMV-SPORT6 vector containing a mouse full-length Cdc6 cDNA (clone 4946685, GenBank accession no. BG919477) that was purchased from Invitrogen. The mutated cDNA was completely sequenced and used as a template for in vitro transcription.
In Vitro Synthesis of dsRNA and Capped RNA
Two dsRNAs were used to target mouse Cdc6 mRNA. The pT7T3D-PacI vector containing a full-length mouse Cdc6 cDNA was purchased from Invitrogen (clone 477516, GenBank accession no. AI510027). The BglII/NotI fragment was excised from the plasmid to obtain a 1160-base pair (bp) fragment that was used as a template for in vitro transcription. The plasmid was linearized using XhoI and HindIII, purified by agarose gel electrophoresis, and used as the template for SP6 and T7 RNA polymerases (Promega, Madison, WI) to obtain sense and antisense RNAs. In vitro transcription and annealing were performed as described previously [19]. The second Cdc6 dsRNA was obtained using MEGAscript® RNAi Kit (Ambion, Austin, TX). A PCR strategy in which the T7 sites were added on both sides of the template was used to generate template for in vitro transcription. The Egfp dsRNA also was prepared as a control dsRNA for injections. Primers for Cdc6 were 5'-AGGATCCTAATACGACTCACTATAGGGAGAGCGATGACAACCTGTGCAA-3' and 5'-ACTCGAGTAATACGACTCACTATAGGGAGACTGTCCGTGAGATCTAGGGTA-3'. Primers for Egfp were 5'-AGGATCCTAATACGACTAACTATAGGGAGAATGGTGAGCAAGGGCGAGGA-3' and 5'-ACTCGAGTAATACGACTCACTATAGGGAGAGCGGCCGCTTTACTTGTACA-3'. The length of the dsRNA fragment was 780 bp for Cdc6 and 712 bp for Egfp.
Polyadenylated capped mRNA for injections was obtained using mMESSAGE mMACHINE T7 Kit and Poly(A) Tailing Kit (Ambion). The template for in vitro transcription was a pCMV-SPORT6 plasmid containing full-length mouse Cdc6 cDNA or point-mutated Cdc6 cDNA, each digested with BanII. The RNA was purified using RNeasy Mini Kit (Qiagen, Inc., Valencia, CA).
Antibodies
The CDC6 was detected using monoclonal antibody sc-9964 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); a dilution of 1:100 was used for Western blot analysis and 1:50 for immunofluorescence. ß-Tubulin was detected with monoclonal antibody T4024 (Sigma-Aldrich, St Louis, MO) at a 1:500 dilution for immunofluorescence. Phosphoserine 10 in histone H3 was detected with 06-570 antibody from Upstate Biotechnology, Inc. (Lake Placid, NY) using a working dilution of 1:500 for immunofluorescence. Lamin A was detected with rabbit polyclonal antibody 2032 (Cell Signaling Technology, Inc., Beverly, MA) at a 1:100 dilution for immunofluorescence. Secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were Cy5-conjugated anti-mouse or anti-rabbit immunoglobulin (Ig) G for immunofluorescence and an alkaline phosphatase-conjugated anti-mouse IgG for immunoblotting.
Immunocytochemistry
Zona pellucida-free oocytes, generated by a brief treatment with acid Tyrode solution, were washed in PBS containing 3 mg/ml of PVP (PBS/ PVP) and fixed in 2% paraformaldehyde in PBS for 30 min at room temperature. All subsequent steps were carried out at room temperature in a humidified chamber. Oocytes were permeabilized in 0.1% Triton X-100 in PBS for 15 min, washed through three drops of PBS/PVP, and then blocked in PBS containing 0.1% BSA and 0.01% Tween-20 for 15 min. The oocytes were then incubated for 1 h in the presence of the primary antibody diluted in blocking solution. The cells were washed through three drops of blocking solution for 15 min each and then incubated for 60 min in the dark with a conjugated secondary antibody. The DNA was stained with 1 µM SYTOX Green (Molecular Probes, Eugene, OR). The cells were then washed and mounted under a coverslip with gentle compression in VectaShield antibleaching solution (Vector Labs). Fluorescence was detected on a Leica TCS SP laser-scanning confocal microscope.
Immunoblotting
Samples were separated in a 10% SDS-PAGE gel and transferred to a polyvinylidene fluoride (PVDF) membrane using semidry transfer. Membranes were blocked with 5% fetal calf serum or 5% teleostein gelatin (Sigma-Aldrich) dissolved in Tris-buffered saline containing 0.1% Tween 20 (TTBS) for 1 h at room temperature. Primary and secondary antibodies were diluted in TTBS, and the membrane was washed after each incubation. The signal was developed using ECF Western Blotting System (Amersham Biosciences, Piscataway, NY) and detected using a Storm 860 PhosphorImager and ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Kinase Assays
The activities of mitogen-activated protein kinase (MAPK) and MPF in single eggs were determined as previously described [19].
Statistical Analysis
One-way ANOVA or Student t-test was used to evaluate the difference between groups, and differences at P < 0.05 were considered to be significant. Prism software (Graph Pad Software Inc., San Diego, CA) was used to perform statistical analyses.
| RESULTS |
|---|
|
|
|---|
Previous reports have shown that in various species, including mouse, CDC6 is not present in growing oocytes and is detected after resumption of meiosis [1, 20, 21]. We quantified the amount of Cdc6 mRNA before meiotic maturation in GV-intact oocytes and after maturation in metaphase II-arrested eggs using real-time RT-PCR. We found that the amount of Cdc6 mRNA decreases by approximately 50% following maturation (Fig. 1A). Immunoblot analysis revealed that CDC6 protein was not detected in GV-intact oocytes but was detected after GVBD (Fig. 1B). This maturation-associated increase was confirmed by immunocytochemistry. No detectable signal was observed in GV-intact oocytes, but a clear signal was localized to chromosomes of the metaphase II-arrested egg (Fig. 1C). Thus, degradation of Cdc6 mRNA was apparently coupled with its translation.
|
CDC6 Overexpression During Resumption of Meiosis
Overexpression of CDC6 in somatic cells blocks the cell cycle at the G2/M-phase transition by activating CHEK1 kinase, which in turn prevents activation of cyclin B/CDK1 complex that permits this transition [12]. As mentioned above, CDK1 activity is low in vertebrate oocytes arrested at the G2/M-phase transition and in somatic cells at the G2 phase. Activation of CDK1 is required for GVBD. We were interested in establishing if the overexpression of CDC6 in oocytes inhibits GVBD by inhibiting CDK1 activation. Full-length Cdc6 mRNA without the 3'-untranslated region (UTR) regulatory sequences was prepared in vitro and microinjected into oocytes blocked at the GV stage with IBMX [18]. A control group was injected with in vitro-transcribed Egfp mRNA. Both groups of oocytes were arrested at the GV stage for additional 2 h after microinjection to allow expression and then matured for 18 h. Accumulation of the newly synthesized proteins was detected within 2 h following microinjection of the mRNAs (data not shown). Results of three independent experiments indicated no difference in the extent of resumption of meiosis following injection with either Egfp or Cdc6 mRNA (Fig. 2A), and no difference was found in the kinetics of GVBD in both groups (data not shown). Thus, overexpression of CDC6 presumably did not inhibit CDK1 activation.
|
Immunolocalization of CDC6 in microinjected oocytes showed that ectopically expressed CDC6 was localized on chromatin and the spindle, which was similar to that of endogenous CDC6 (Figs. 1C and 2B). The higher level of fluorescence in the oocytes injected with Cdc6 mRNA compared with that in controls was confirmed by immunoblot analysis (Fig. 2C). In summary, the results of these experiments indicate that overexpression of CDC6 by at least 30-fold (as determined by quantifying the signal intensity in Fig. 2C) when compared to the endogenous amount of CDC6 does not inhibit CDK1 activation.
Overexpression of Selected CDC6 Mutants
Previous work has shown that selected mutants of CDC6, including S74 converted to alanine and deletion of the Cy motif, are less efficient in arresting the cell cycle, whereas mutation of other serine sites (S54 and S107) showed the same efficiency as wild-type CDC6 [12]. To analyze whether the phosphorylation state of CDC6 is important for blocking meiotic progression, we generated Cdc6 mRNAs with serines 55, 75, and 108 mutated into alanines (A mutation) or into aspartic acid (D mutation), and we injected mRNAs encoding these mutant forms into oocytes. Results of two independent experiments showed that both mutations did not increase the ability of CDC6 to prevent resumption of meiosis (Fig. 3A).
|
In mammals, CDC6 phosphorylation is responsible for its translocation to the cytoplasm; the unphosphorylated form is retained in the nucleus [2224]. When we analyzed the localization of CDC6 mutants in oocytes before GVBD, we found that the A mutation was almost exclusively localized in the nucleus, which is consistent with previous results obtained in somatic cells (data not shown). Both immunolocalization (Fig. 3B) and immunoblotting (Fig. 3C) of eggs after maturation revealed a higher level of expression of the A form compared to the D form, even though similar amounts of the corresponding mRNAs were injected. The low level of expression of the D form precluded its localization in GV-intact oocytes.
CDC6 Is Essential for Spindle Formation During Oocyte Maturation
We used RNAi to assess the function of CDC6 in resumption of meiosis (i.e., to test whether CDC6 has additional functions beyond DNA replication). Two different dsRNAs (length, 1160 and 780 bp) were prepared to target Cdc6 mRNA in GV-intact oocytes. After 24 h in culture medium containing IBMX to inhibit maturation, the amount of Cdc6 mRNA was assayed by real-time PCR. As anticipated, the amount of Cdc6 mRNA was dramatically reduced (Fig. 4A). When the oocytes were allowed to resume meiosis by transferring them to inhibitor-free medium, the maturation-associated increase in CDC6 protein was not observed, as evidenced by a decrease in the intensity of the fluorescent signal (Fig. 4B).
|
When these injected and matured oocytes were analyzed morphologically, it became apparent that although they underwent GVBD, they failed to reach metaphase I (MI); this effect was consistently observed in several experiments using long (1160-bp) or short (780-bp) dsRNA. Morphological analysis of the injected oocytes showed that the first polar body was not extruded and that DNA formed a hollow sphere, as revealed by optical sectioning, instead of a metaphase plate (Fig. 5B). We did not detect a spindle in oocytes injected with Cdc6 dsRNA using a ß-tubulin antibody; in contrast, a spindle was detected in oocytes injected with Egfp dsRNA (Fig. 5A). Although the chromosomes were condensed (a hallmark of cells undergoing mitosis/meiosis, because they stained for histone H3 phosphorylated on S10), they did not form visible bivalents (Fig. 5, C and D). In addition, the oocytes had undergone nuclear envelope breakdown, because lamin A was not detected (data not shown). Time-course studies revealed that the spindle never formed (data not shown).
|
In yeast and in mammals, CDC6 directly interacts with cyclin/CDK complexes, but the physiological importance of this interaction in mammals is not known [23, 25]. Activities of MPF and MAPK were measured in Cdc6 dsRNA-injected oocytes to establish that the inhibitory effect on progression to MI was not because of the failure of these kinases to become fully activated. No apparent difference was noted in the activities of these kinases following maturation of oocytes injected with either Cdc6 or Egfp dsRNA (Fig. 6).
|
| DISCUSSION |
|---|
|
|
|---|
As mentioned in Results, overexpression of CDC6 in somatic cells blocks the cell cycle at the G2/M-phase transition via CHEK1 kinase [12]. Our results show that in contrast to somatic cells, resumption of meiosis (i.e., the G2/M-phase transition) is not prevented by overexpression of CDC6. This difference could be explained by the requirements of different CDC25 isoforms for cyclin B/ CDK1 activation in somatic cells and in mouse oocytes. CDC25B, which is essential for meiotic resumption in mouse oocytes, is dispensable in the somatic cell cycle [27]. In somatic cells, an activated DNA-replication checkpoint inhibits CDC25A and CDC25B, with MAPK being required for CDC25B inhibition [28, 29]. In mouse oocytes, however, MAPK is activated after MPF because of the recruitment of Mos mRNA after GVBD [30]. Thus, overexpression of CDC6 may not inhibit GVBD (i.e., the G2/M-phase transition), because CDC25B is not inhibited by the low level of MAPK activity before GVBD.
We also observed that CDC6 with N-terminal serines mutated to aspartic acid is less stable in oocytes. This is reminiscent of yeast, in which CDC6 phosphorylation targets its destruction [3134], and differs from mammals, in which phosphorylation promotes nuclear export of CDC6 [2224]. However, the amount of CDC6 is relatively constant throughout cell cycle [9, 11]. Even so, it should be noted that data regarding the stability of exogenous CDC6 in mammalian cells are conflicting. For example, both mutations (CDK consensus serines into alanines or aspartic acid) are stably expressed from plasmids in HeLa cells [35], whereas using cell extracts, exogenous CDC6 is degraded in CDK-dependent fashion during the S phase [8].
In mammals, CDC6 is not destroyed after the initiation of DNA replication; rather, it persists bound to chromatin throughout the cell cycle, suggesting that it may have other functions during the late S phase or mitosis [35]. In support of this hypothesis, the present results show that CDC6 is critical for meiotic progression of mouse oocytes, because oocytes with a reduced amount of CDC6 fail to form a spindle.
An inactive form of CDC6 also can arrest yeast in mitosis [36]. Deleting both Cdc6 alleles in yeast results in incomplete mitosis, with randomly distributed chromosomes and cells with a DNA content less than 1C. Mutation in the Walker A motif, which is essential for ATP binding and hydrolysis [36], results in expression of a nonfunctional CDC6, and the cells arrest in anaphase before chromosome segregation and have elongated spindles. This block, which is independent of a DNA-replication checkpoint and requires both an intact Cy box (mediating the binding of proteins to CDK cyclins in eukaryotes [36]) and CDK phosphorylation consensus sites, is overcome by increased CDK activity. Of interest is that in mouse oocytes with decreased CDC6 protein, CDK1 activity displays its normal maturation-associated increase in activity, yet the oocytes do not form a spindle and enter MI.
Other DNA replication proteins also are involved in chromosome condensation and distribution during mitosis. The ORC subunits 2, 5, and 6 and MCM10, which are all involved during the initial steps of DNA replication, also are required during mitosis, because decreasing the amount of these proteins leads to incorrect chromosome condensation and distribution or defects in cytokinesis [3741]. In this regard, CDC6 also appears to be involved in chromosome condensation, because decreasing the amount of oocyte CDC6 results in abnormal chromosome condensation and failure to form bivalents.
The present results have unmasked a new function for CDC6 that apparently is unrelated to DNA replication namely, that CDC6 is critical for meiotic progression of mouse oocytes, particularly formation of a meiotic spindle. The molecular mechanism underlying this new function and why the chromosomes are found condensed on the surface of a hollow sphere are the subject of future investigations.
| FOOTNOTES |
|---|
2 Correspondence: Richard Schultz, Department of Biology, University of Pennsylvania, 415 South University Avenue, Philadelphia, Pennsylvania 19104-6018. FAX: 215 898 8780; rschultz{at}mail.sas.upenn.edu ![]()
Received: 18 August 2004.
First decision: 3 September 2004.
Accepted: 3 September 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Metchat, M. Akerfelt, C. Bierkamp, V. Delsinne, L. Sistonen, H. Alexandre, and E. S. Christians Mammalian Heat Shock Factor 1 Is Essential for Oocyte Meiosis and Directly Regulates Hsp90{alpha} Expression J. Biol. Chem., April 3, 2009; 284(14): 9521 - 9528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ihara, P. Stein, and R. M. Schultz UBE2I (UBC9), a SUMO-Conjugating Enzyme, Localizes to Nuclear Speckles and Stimulates Transcription in Mouse Oocytes Biol Reprod, November 1, 2008; 79(5): 906 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lynch, A. Seyfert, B. Eads, and E. Williams Localization of the Genetic Determinants of Meiosis Suppression in Daphnia pulex Genetics, September 1, 2008; 180(1): 317 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lau, T. Tsuji, L. Guo, S.-H. Lu, and W. Jiang The role of pre-replicative complex (pre-RC) components in oncogenesis FASEB J, December 1, 2007; 21(14): 3786 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Murchison, P. Stein, Z. Xuan, H. Pan, M. Q. Zhang, R. M. Schultz, and G. J. Hannon Critical roles for Dicer in the female germline Genes & Dev., March 15, 2007; 21(6): 682 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Romanova, M. Anger, O. V. Zatsepina, and R. M. Schultz Implication of Nucleolar Protein SURF6 in Ribosome Biogenesis and Preimplantation Mouse Development Biol Reprod, November 1, 2006; 75(5): 690 - 696. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |